Wancura Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-04-2024
- Paid Up Capital ₹ 2.00 M
as on 24-04-2024
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 4.00 M
as on 24-04-2024
- Revenue 13.18%
(FY 2017)
- Profit 45.17%
(FY 2017)
- Ebitda 24.31%
(FY 2017)
- Net Worth 555.14%
(FY 2017)
- Total Assets 42.71%
(FY 2017)
About Wancura Life Sciences
- CIN/LLPIN
U24233TG2014PTC094161
- Company No.
094161
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2014
- Date of AGM
25 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Wancura Life Sciences Private Limited offer?
Wancura Life Sciences Private Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Ointment, Psoriasis Ointment, Permethrin Cream.
Who are the key members and board of directors at Wancura Life Sciences?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bharani Returi | Director | 26-May-2014 | Current |
Chandrasekhar Maruthi | Director | 26-May-2014 | Current |
Financial Performance of Wancura Life Sciences.
Wancura Life Sciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 13.18% increase. The company also saw a substantial improvement in profitability, with a 45.17% increase in profit. The company's net worth Soared by an impressive increase of 555.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Wancura Life Sciences?
In 2017, Wancura Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Union Bank Of India Creation Date: 06 Aug 2015 | ₹4.00 M | Satisfied |
How Many Employees Work at Wancura Life Sciences?
Unlock and access historical data on people associated with Wancura Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wancura Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wancura Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.